We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
2026
Liberty Media Series A
FWONA
$23.6B
$25K ﹤0.01%
731
+189
+35% +$6.6K
IHI icon
2027
iShares US Medical Devices ETF
IHI
$3.37B
$25K ﹤0.01%
618
-88,404
-99% -$3.35M
IIIV icon
2028
i3 Verticals
IIIV
$342M
$25K ﹤0.01%
+837
New +$20.7K
MCRI icon
2029
Monarch Casino & Resort
MCRI
$2.23B
$25K ﹤0.01%
583
+88
+18% +$3.85K
MMYT icon
2030
MakeMyTrip
MMYT
$5.64B
$25K ﹤0.01%
1,015
+767
+309% +$19.4K
MOV icon
2031
Movado Group
MOV
$841M
$25K ﹤0.01%
915
-12,213
-93% -$384K
MUX icon
2032
McEwen Inc
MUX
$1.18B
$25K ﹤0.01%
1,430
+860
+151% +$12.6K
VC icon
2033
Visteon
VC
$2.78B
$25K ﹤0.01%
433
-4,874
-92% -$298K
SWN
2034
DELISTED
Southwestern Energy Company
SWN
$25K ﹤0.01%
7,883
+7,033
+827% +$27.3K
CAJ
2035
DELISTED
Canon, Inc.
CAJ
$25K ﹤0.01%
870
-197
-18% -$5.64K
TPTX
2036
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$25K ﹤0.01%
+606
New +$21.6K
RPAI
2037
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$25K ﹤0.01%
2,130
-485
-19% -$5.94K
FIT
2038
DELISTED
Fitbit, Inc. Class A common stock
FIT
$25K ﹤0.01%
5,752
+5,277
+1,111% +$26.6K
DZSI
2039
DELISTED
DZS Inc. Common Stock
DZSI
$25K ﹤0.01%
1,935
+1,713
+772% +$20.3K
TIVO
2040
DELISTED
Tivo Inc
TIVO
$25K ﹤0.01%
+3,351
New +$26.9K
WPG
2041
DELISTED
Washington Prime Group Inc.
WPG
$25K ﹤0.01%
+733
New +$30.1K
BANF icon
2042
BancFirst
BANF
$3.8B
$24K ﹤0.01%
432
+390
+929% +$21.6K
BTG icon
2043
B2Gold
BTG
$6.64B
$24K ﹤0.01%
8,052
-57,988
-88% -$159K
CARS icon
2044
Cars.com
CARS
$660M
$24K ﹤0.01%
1,213
+183
+18% +$3.91K
CIB icon
2045
Grupo Cibest SA
CIB
$21.1B
$24K ﹤0.01%
483
-1,059
-69% -$52.9K
CMPR icon
2046
Cimpress
CMPR
$2.31B
$24K ﹤0.01%
+260
New +$23.4K
CVGW
2047
DELISTED
Calavo Growers
CVGW
$24K ﹤0.01%
248
-61
-20% -$5.7K
DNOW icon
2048
DNOW Inc
DNOW
$2.99B
$24K ﹤0.01%
1,653
-16,474
-91% -$236K
EVI icon
2049
EVI Industries
EVI
$180M
$24K ﹤0.01%
616
-386
-39% -$14.3K
FMC icon
2050
FMC
FMC
$1.33B
$24K ﹤0.01%
296
-4,664
-94% -$366K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.